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Rational Redox Tuning of Transition Metal Sites: 
Learning from Superoxide Reductase 
Marius Horch,*a,b 
Using superoxide reductase as a model system, a computational 
approach reveals how histidine tautomerism tunes the redox 
properties of metalloenzymes to enable their catalytic function. 
Inspired by these experimentally inaccessible insights, non-
canonical histidine congeners are introduced as new versatile tools 
for the rational engineering of biological transition metal sites. 
Histidine (His) is an N-heterocyclic aromatic amino acid with a 
substituted imidazole (Im) side chain that plays a major role as 
a ligand in metalloproteins.1,2 In its neutral, single-protonated 
form, the Im side chain of His adopts two tautomeric forms with 
a proton bound either to Nɷ or Nɸ (Fig. 1). ? In aqueous solution, 
protonation of Nɸ is favoured, most likely due to intramolecular 
interactions.3 ?5 In proteins, however, these interactions cannot 
occur, and both tautomers are found, e.g., as conserved ligands 
ŽĨ ŵĞƚĂů ƐŝƚĞƐ ? ^Ž ĨĂƌ ? EĂƚƵƌĞ ?Ɛ ĐŚŽŝĐĞ ĨŽƌ ĞŝƚŚĞƌ ƚĂƵƚŽŵĞƌ ŝŶ
individual proteins is not understood. 
 Superoxide reductase (SOR) is a non-heme iron enzyme that 
catalyses the reduction of O2о ? to H2O2, thereby cycling between 
ferric and ferrous forms.6 ?8 Apart from an axial cysteine (Cys) 
and four equatorial His ligands, the ferrous form has a vacant 
coordination site, which is typically occupied by the substrate, a  
Figure 1: Tautomeric forms of His and related substituted imidazole compounds. 
Adopting a common nomenclature for His, Nɷ and Nɸ represent the two non-
equivalent nitrogen atoms. In case of MeIm, tautomers I and II are typically 
designated as 5-MeIm and 4-MeIm, respectively. 
Figure 2: (a) Crystal structure of superoxide reductase (SOR) from Ignicoccus 
hospitalis exhibiting the conserved (Nɷ)1(Nɸ)3 coordination pattern (PDB: 4BK8).9 
(b) Minimum model of the SOR active site featuring one 4-MeIm and three 5-
MeIm ligands mimicking this pattern. Both structures correspond to the ferric 
resting state. 
solvent molecule, or a glutamate (Glu) ligand in the ferric state  
 (Fig. 2a).10 ?18 Containing a conserved pattern of one Nɷ- and 
three Nɸ-coordinated His ligands (Fig. 2a),10 ?14 SOR provides a 
valuable model system to explore the role of His tautomerism 
in metalloenzymes. 
 For both electronic (vide infra) and steric reasons, metal 
coordination via Nɸ is clearly favoured in non-proteinaceous 
complexes of alkyl-substituted imidazole.19 Consistently, Nɸ 
coordination dominates in metalloproteins as well, indicating a 
distinct role of Nɷ-coordinated His in, e.g., SOR. Nonetheless, 
most previous studies on this enzyme have paid little attention 
to the four His ligands, despite their dominating contribution to 
a set of only six strictly conserved amino acids.7,8 § Since 
tautomeric forms of amino acids cannot be interchanged by site 
directed mutagenesis, theoretical methods (see SI2 and SI3) are 
used in the present study to demonstrate how intrinsic 
differences between His tautomers affect the properties of 
(biological) metal sites, using SOR as an example. Isosteric His 
congeners are also studied and introduced as novel means for 
rational metalloenzyme design.  
 Bonding interactions of His with a transition metal ion are 
governed by the Lewis acid-base properties of the coordinating 
nitrogen site of the Im side chain. Thus, it is tempting to propose  
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Figure 3: Calculated standard reduction potentials of SOR active site models with different numbers of 4-MeIm (and 5-MeIm) ligands. All values represent potential 
differences ȟܧ ? between the species of interest and a model reflecting native SOR coordination, (4-MeIm)1(5-MeIm)3. ȟܧ ? values were derived from gas-phase standard 
Gibbs free energies (left) as well as aqueous-solution standard Gibbs free energies obtained using IEFPCM (center) and SMD (right) solvation models. Calculations were 
performed using BP86 (black), TPSSh (red), and PBE0 (blue) density functionals. 
Figure 4: Structural comparison of 5-MeIm (highlighted in grey) with different methylazole compounds used as ligands in computational models of non-native SOR 
active site variants: (a) 5-methyl-1,3-thiazole, (b) 5-methyl-1,3-oxazole, (c) 5-methyl-1H-imidazole (5-MeIm), (d) 4-methyl-1H-pyrazole, (e) 5-methyl-1H-1,2,3-triazole, 
(f) 5-methyl-1H-1,2,4-triazole, and (g) 5-methyl-tetrazolate. 
that characteristics of a (biological) metal centre, e.g. substrate 
specificity, binding, and conversion, are subtly tuned by the 
different donor-acceptor properties of the two His tautomers. 
To evaluate this proposal, the simpler case of Hisо interacting 
with a proton (yielding neutral His) is considered first. Since 
intrinsic differences between the two nitrogen sites are masked 
by intramolecular interactions in non-proteinaceous His,3 ?5 5-
methylimidazole (5-MeIm) and 4-methylimidazole (4-MeIm), 
respectively, are used as in silico models of Nɷ- and Nɸ-
protonated His instead. 4-MeIm is found to exhibit a lower 
standard Gibbs free energy, a higher N ?H stretch frequency, 
and a shorter N ?H bond length (Table S1). Although subtle, the 
differences are self-consistent, largely insensitive towards 
computational details (Tables S1 and S2), and in line with 
experimental and other theoretical data.5,20,21,22 Moreover, the 
same N ?H bond-length trend is observed for the imidazolium 
cation, as also reported by others.20,21 Since the N ?H bond of Im 
derivatives is built from electron density of the Im ring, binding 
of a proton can be interpreted in terms of Lewis basicity. Thus, 
it can be concluded that Nɸ is a slightly stronger and/or harder 
Lewis base than Nɷ. 
 Since interactions of substituted imidazole derivatives with 
a transition metal ion might differ from those with a proton, 
inter alia ?ďǇŝŶǀŽůǀŝŶŐʋ-interactions,23 effects on metals sites 
might be more pronounced. Assuming a noticeable effect, 
different bonding properties of the two His tautomers are 
expected to alter the energies of metal d-orbitals, which could 
in principle affect substrate binding. For SOR, however, this 
scenario can be ruled out since the experimentally observed 
end-on binding of a dioxo species was well reproduced by 
computational models with unsubstituted Im ligands,10,15,16,24 
 Alternatively, altered energies of frontier orbitals could 
affect catalysis by tuning the standard reduction potential ܧ ? of 
the metal site. To evaluate this hypothesis, differences in ܧ ? 
between several variants of an SOR active site minimum model 
containing different numbers of 4-MeIm and 5-MeIm ligands 
(Fig. 1b; SI2 and SI3) were calculated. Specifically, models with 
an equatorial (4-MeIm)x(5-MeIm)y ĐŽŽƌĚŝŶĂƚŝŽŶƉĂƚƚĞƌŶ ? ?чǆч
4; y = 4  ? x) were compared with a (4-MeIm)1(5-MeIm)3 model 
reflecting the native SOR active site with one Nɷ- and three Nɸ-
coordinated His ligands (Fig. 1). According to these calculations, ܧ ? increases systematically with the number of Nɷ-coordinated 
4-MeIm ligands (Fig. 3). This finding is independent from the 
level of theory, the inclusion and implementation of implicit 
aqueous solvation, and technical details of standard Gibbs free 
energy calculations (Fig. 3; Fig. S1), indicating that the observed 
trend is firmly defined by the intrinsic electronic properties of 
the two MeIm tautomers. Coordination by Nɸ (Nɷ) stabilizes the  
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Figure 5: Calculated standard reduction potentials of SOR active site models with 
a non-native (4-MeIm)1(5-MeIm)2(MeAz)1 coordination pattern, where MeAz 
refers to a methylazole ligand, as indicated (see Fig. 4). All values represent 
potential differences ȟܧ ? between the species of interest and a model reflecting 
native SOR coordination, (4-MeIm)1(5-MeIm)3. ȟܧ ? values were derived from gas-
phase standard Gibbs free energies obtained using the TPSSh density functional. 
ferric (ferrous) forms of the models, which is in line with the 
finding that Nɸ is a harder and/or stronger Lewis base than Nɷ. 
Standard reduction potentials of the investigated variants cover 
a range of ca. 300 mV, i.e., on average, each included 4-MeIm 
ligand increases ܧ ? by ca. 75 mV (Fig. 3; Fig. S1), demonstrating 
the (biological) relevance of the observed effect. In particular, 
inclusion of a single Nɷ-coordinated 4-MeIm ligand, analogous 
to native SOR, increases ܧ ? by up to 150 mV (Fig. 3; Fig. S1). 
 Despite the clear effects of His tautomerism, redox tuning in 
SOR might appear startling at first since reduction potentials of 
SORs from different organisms span a range of 170 mV.18,25,26 
However, the experimentally probed redox transition between 
the ferric resting form and the ferrous state of the enzyme 
involves Glu dissociation from the iron ion in most cases. Thus, 
experimental ܧ ? values include ȟܩ ? contributions from the 
actual redox transition as well as Glu dissociation and protein 
rearrangement. Since the latter term depends on the flexibility 
of the Glu-harbouring domain, experimentally derived ܧ ? values 
are unsuited for evaluating the driving force for redox reactions 
with the substrate, antagonists, or electron donors. 
 From a thermodynamic point of view, tuning the SOR active 
site potential may be relevant to enable efficient and selective 
substrate conversion. On the one hand, the potential should be 
low enough to provide a driving force for O2о ? reduction (ܧ ?ᇱ ൌ ? ? ?)27; on the other hand, it should be high enough to limit 
ƚŚĞĨŽƌŵĂƚŝŽŶŽĨŚŝŐŚůǇƌĞĂĐƚŝǀĞ,K ?ƌĂĚŝĐĂůƐĨƌŽŵ,2O2 (ܧ ?ᇱ ൌ ? ? ?)27, the product of the SOR catalytic reaction. Notably, 
this situation implies that the SOR active site potential has to be 
finely tuned, and the inclusion of a single Nɷ-coordinated His 
ligand appears to provide the best balance between the two 
requirements. Increasing the reduction potential relative to an 
all-Nɸ coordination would also disfavour undesired high-valent 
iron species, as formed at the congeneric active site of 
cytochrome P450, where the four-histidine pattern of SOR is 
substituted by a porphyrin.28 Thus, redox tuning of SOR may, 
together with other effects,8,29,30 account for different 
reactivities of the two enzymes. 
 Tuning the SOR reduction potential could also be relevant 
from a kinetic point of view.  Increasing the active site potential 
relative to an all-Nɸ pattern would accelerate outer-sphere 
electron transfer between cellular reductants and the SOR 
active site without impeding the inner-sphere reduction of 
O2о ?.29,31 This could be particularly relevant for 2Fe-SORs, where 
intramolecular long-range electron transfer from a second iron 
site likely proceeds via a redox-active tyrosine.32 
 Differences in the bonding properties of the two nitrogen 
sites also explain previous observations on SOR. Nɷ-coordinated 
4-ethylimidazole (4-EtIm) was found to dissociate from a 
computational active site model upon deprotonation of the 
EtIm ligand in trans position, but no such reaction was observed 
for the Nɸ-coordinated 5-EtIm ligands.26 Considering the trans 
ŝŶĨůƵĞŶĐĞĂƌŝƐŝŶŐĨƌŽŵƚŚĞŵŽƌĞƉƌŽŶŽƵŶĐĞĚʍ-donation of the 
imidazolate anion,1,33 this effect can be explained by the lower 
Lewis basicity of the Nɷ site. Remarkably, imidazolate formation 
is prevented in the enzyme by H-bonding to a conserved proline 
of previously unknown function,26 thereby protecting the active 
site from dissociation of Nɷ-coordinated histidine. 
 Inspired by these findings, the impact of alkyl-substituted 
azoles that can serve as isosteric substitutes for His (Fig. 4) were 
considered as well. Using advanced genetic engineering,34 non-
canonical amino acids with such side chains could be utilized, 
e.g., to selectively tune the (redox) properties of SOR and other 
His-containing metalloproteins without interfering with their 
overall structure. To illustrate this strategy, standard reduction 
potentials were calculated for a series of SOR active site models 
in which one of the 5-MeIm ligands was replaced by another 
methylazole (Fig. 4 and Fig. 5; Fig. S2). Overall, changes of the 
standard reduction potential observed for these models are 
more pronounced than those obtained upon single-tautomer 
exchange (vide supra), confirming that steric contributions to 
the calculations are low. Subtle effects on ܧ ? are observed for 
methylated thiazole and oxazole congeners, while two 
methyltriazole tautomers are found to increase the standard 
reduction potential of the native SOR model by up to 200 mV. 
The largest effects can be observed for methylated pyrazole and 
tetrazolate variants, whose standard reduction potentials differ 
from that of the native ^KZŵŽĚĞůďǇĐĂ ?о ? ? ?ĂŶĚн ? ? ?ŵs ?
respectively. Within the protein, potential changes will also 
depend on factors not included in these computational models, 
but the calculations clearly demonstrate the possibility to 
considerably tune biological transition metal sites by sterically 
conservative exchange of a single coordinating amino acid. 
 In the present study, microscopic Lewis basicities were 
assigned to the nitrogen sites of His, demonstrating that Nɸ is a 
stronger and/or harder Lewis base than Nɷ. This effect was 
shown to systematically tune the standard reduction potential 
of a computational SOR model, and, thus, it is proposed that His 
tautomerism is relevant for the catalytic function of this enzyme 
and the redox tuning of biological metal sites in general. 
Building on this idea, standard reduction potentials of SOR 
models containing non-native azole ligands were evaluated. 
These calculations show that a drastic change of redox 
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properties can be evoked by substituting a single His ligand with 
an isosteric non-canonical amino acid. This approach can be 
expanded towards polysubstituted N-heterocycles, applied to 
other amino acids, and used to design tailored metalloenzymes 
with higher catalytic activity or altered spectra of substrates and 
products. The author thinks that this so-far unexplored strategy 
provides an interesting perspective for bioinorganic research as 
well as synthetic biology and chemistry. 
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 ? Nɷ and Nɸ have also been termed Nʋ and Nʏ, respectively. N(1) ?
H and N(3) ?H abbreviations have also been used to designate the 
two His tautomers, but atom numbering is ambiguous: In 
biochemical literature, N(1) and N(3) refer to Nɷ and Nɸ, 
respectively, while the opposite assignment is used in most other 
fields. 
§ A recent amino acid alignment indicates that only three of the 
four histidines are strictly conserved.6 However, it is not known 
whether sequences lacking the fourth His represent functional 
SORs and how these may differ from their canonical counterparts. 
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